[PDF][PDF] TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis

N Alaaeddine, J Sidaoui, G Hilal, R Serhal… - European cytokine …, 2012 - researchgate.net
Background and aim: tumor necrosis factor (TNF)-plays a significant role in the
pathogenesis of nonalcoholic steatohepatitis (NASH). A few studies have confirmed high …

Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis

S Abiru, K Migita, Y Maeda, M Daikoku, M Ito… - Liver …, 2006 - Wiley Online Library
Background: Although the pathogenesis of non‐alcoholic steatohepatitis (NASH) remains
poorly understood, proinflammatory cytokines seem to play an important role in the process …

Gene expression of tumor necrosis factor [alpha] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

J Crespo, P Fern, M Hern, M Mayorga, F Pons-Romero - Hepatology, 2001 - Elsevier
The main objective of this study was to analyze the pathogenic role of the tumor necrosis
factor [alpha](TNF-[alpha]) system in the development of nonalcoholic steatohepatitis …

Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis

N Torer, S Ozenirler, A Yucel, N Bukan… - Scandinavian journal of …, 2007 - Taylor & Francis
Objective. Non-alcoholic steatohepatitis (NASH) is a form of chronic hepatitis. The
pathogenesis of NASH has been dealt with in only a few studies and so it has not been …

Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis

K Tokushige, M Takakura, N Tsuchiya-Matsushita… - Journal of …, 2007 - Elsevier
BACKGROUND/AIMS: Tumor necrosis factor (TNF) is considered to play a role in the
second hit of non-alcoholic steatohepatitis (NASH). To clarify the effects of TNF in NASH we …

Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH)

C Schramm, A Schneider, A Marx… - Zeitschrift für …, 2008 - thieme-connect.com
Die Prävalenz der nicht alkoholischen Steatohepatitis (NASH) nimmt zu. Derzeit steht keine
medikamentöse Therapie der NASH zur Verfügung. Bei der Progression der Fettleber zur …

Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells

A Kado, T Tsutsumi, K Enooku, H Fujinaga… - Journal of …, 2019 - Springer
Background Nonalcoholic fatty liver disease (NAFLD) consists of nonalcoholic fatty liver
(NAFL) and nonalcoholic steatohepatitis (NASH); the latter progresses to liver cirrhosis and …

Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of …

L Miele, A Forgione, G La Torre, V Vero, C Cefalo… - Translational …, 2009 - Elsevier
Hyaluronic acid (HA) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are reliable
markers of liver fibrosis and are closely linked to the proinflammatory status. In this pilot …

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

M Yoneda, H Mawatari, K Fujita, H Iida… - Journal of …, 2007 - Springer
Background The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide
spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained …

Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis

V Potoupni, M Georgiadou… - Journal of …, 2021 - Wiley Online Library
Abstract Background and Aim To synthesize data on circulating tumor necrosis factor (TNF)‐
α levels between patients with histologically confirmed non‐alcoholic fatty liver disease …